SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Morgan Stanley Maintains Equal-Weight on Ironwood Pharmaceuticals, Lowers Price Target to $11

Morgan Stanley maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-Weight and lowers the price target from $12 to $11.

Benzinga · 05/07/2020 12:41

Morgan Stanley maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Equal-Weight and lowers the price target from $12 to $11.